Destiny Pharma to attend DRIVE-AB (Driving reinvestment in R&D and the responsible use of antibiotics) meeting in London on February 9th

Destiny Pharma has been invited to attend the DRIVE-AB (Driving reinvestment in R&D and the responsible use of antibiotics) meeting to be held at the Royal Automobile Club in London on the February 9th 2015. DRIVE-AB is a project composed of 16 public and 7 private partners from 12 countries that is funded by the Innovative Medicines Initiative (IMI): IMI is a joint undertaking between the European Union and the European Pharmaceutical Industry Association (EFPIA) and is focused on driving reinvestment in R&D for antibiotics and advocating their responsible use.